A Survey of Head and Neck Cancer Curriculum in United States Speech Language Pathology Masters Programs

2010 ◽  
Vol 25 (4) ◽  
pp. 556-559 ◽  
Author(s):  
Hon K. Yuen ◽  
Michelle Fallis ◽  
Bonnie Martin-Harris
Keyword(s):  
United States ◽  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Speech Language Pathology ◽  
Language Pathology

The Speech-Language Pathologist's Role in Screening for Head and Neck Cancer

2012 ◽  
Vol 22 (1) ◽  
pp. 6-13
Author(s):  
Edie R. Hapner
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Healthcare Professionals ◽  
Screening Tool ◽  
Communication Disorders ◽  
Speech Language Pathology ◽  
Speech Language Pathologists ◽  
Cancer Screenings ◽  
Language Pathology

The American Speech-Language-Hearing Association (ASHA)'s Preferred Practice Patterns for the Profession of Speech-Language Pathology (ASHA, 2004) and Prevention of Communication Disorders (ASHA, 1988) advise speech-language pathologists to engage in activities to educate and prevent diseases and disorders that affect speech and swallowing. However, many speech-language pathologists may be unfamiliar with the use of head and neck cancer screening that can be easily integrated into oral mechanism examinations and perceptual voice evaluations. This paper reviews the problem created by the lack of knowledge and reduced risk perception by the general public and healthcare professionals regarding signs, symptoms, and risks for head and neck cancer. A simple six-step screening tool is included to aid the reader in integrating head and neck cancer screenings into a general oral mechanism and speech/voice evaluation.

Using Telepractice to Support the Management of Head and Neck Cancer: Key Considerations for Speech-Language Pathology Service Planning, Establishment, and Evaluation

2017 ◽  
Vol 2 (13) ◽  
pp. 139-146
Author(s):  
Clare L. Burns ◽  
Laurelie R. Wall
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Service Planning ◽  
Current Evidence ◽  
Speech Language Pathology ◽  
Staff Support ◽  
Clinical Patient ◽  
Research Reporting ◽  
Language Pathology

With the rise of technology-enhanced health services, there is a growing opportunity to use telepractice to address the challenges associated with accessing and delivering speech-language pathology head and neck cancer (HNC) services. With an emerging body of research reporting clinical, patient and service benefits, careful planning and coordination of a range of factors are required to integrate these new models into routine speech-language pathology practice. This paper provides a review of current evidence and key professional policy documents to assist clinicians in the development of speech-language pathology HNC telepractice services. Important aspects of service design such as mode and configuration of technology, patient suitability, staff support, and training, as well as strategies for service establishment and evaluation are discussed. Consideration of these aspects is important to ensure that future speech-language pathology HNC telepractice services meet clinical, technical, and operational requirements to support successful service implementation and long-term sustainability.

scholarly journals Epidemiological Trends of Head and Neck Cancer in the United States: A SEER Population Study

2017 ◽  
Vol 75 (12) ◽  
pp. 2562-2572 ◽  
Author(s):  
Moustafa Mourad ◽  
Thomas Jetmore ◽  
Ameya A. Jategaonkar ◽  
Sami Moubayed ◽  
Erin Moshier ◽  
...  
Keyword(s):  
United States ◽  
Head And Neck Cancer ◽  
Head And Neck ◽  
Population Study ◽  
Neck Cancer ◽  
The United States ◽  
Epidemiological Trends

Abstract 1177: Insurance status and racial disparities in mortality for black and white head and neck cancer patients in the United States

2020 ◽  
Author(s):  
Dana R. Marshall ◽  
Joycemary Amponsem ◽  
Billy R. Ballard ◽  
Mohammed A. El Kadmiri ◽  
Young J. Kim ◽  
...  
Keyword(s):  
United States ◽  
Head And Neck Cancer ◽  
Racial Disparities ◽  
Head And Neck ◽  
Cancer Patients ◽  
Neck Cancer ◽  
The United States ◽  
Insurance Status ◽  
Black And White

scholarly journals Fruit and vegetable intake and head and neck cancer risk in a large United States prospective cohort study

2007 ◽  
Vol 122 (10) ◽  
pp. 2330-2336 ◽  
Author(s):  
Neal D. Freedman ◽  
Yikyung Park ◽  
Amy F. Subar ◽  
Albert R. Hollenbeck ◽  
Michael F. Leitzmann ◽  
...  
Keyword(s):  
United States ◽  
Cohort Study ◽  
Head And Neck Cancer ◽  
Cancer Risk ◽  
Head And Neck ◽  
Prospective Cohort Study ◽  
Neck Cancer ◽  
Prospective Cohort ◽  
Vegetable Intake ◽  
Fruit And Vegetable Intake

scholarly journals Assessment of Imaging Utilization and Treatment Patterns for Head and Neck Cancer Patients in the United States

2014 ◽  
Vol 17 (3) ◽  
pp. A98
Author(s):  
B.W. Bresnahan ◽  
R. Alfonso-Cristancho ◽  
H. He ◽  
E. Mendez ◽  
B. Goulart ◽  
...  
Keyword(s):  
United States ◽  
Head And Neck Cancer ◽  
Head And Neck ◽  
Cancer Patients ◽  
Neck Cancer ◽  
The United States ◽  
Treatment Patterns ◽  
Imaging Utilization

Racial disparities in outcome among head and neck cancer patients in the United States: An analysis using SEER-Medicare linked database.

2019 ◽  
Vol 37 (15_suppl) ◽  
pp. 6051-6051 ◽  
Author(s):  
Ikumi Suzuki ◽  
Kevin J. Cullen ◽  
Ranee Mehra ◽  
Søren Bentzen ◽  
Olga G. Goloubeva
Keyword(s):  
United States ◽  
Overall Survival ◽  
Head And Neck Cancer ◽  
African Americans ◽  
Oral Cavity ◽  
Head And Neck ◽  
Cancer Patients ◽  
Ethnic Groups ◽  
Neck Cancer ◽  
The United States

6051 Background: Despite overall decline in cancer mortality, African Americans suffer from higher mortality in most cancer types including cancers of the head and neck. These differences likely result from a complex interplay of clinical and non-clinical factors. We aim to estimate disparities in overall survival across racial groups in HNSCC in the United States. Methods: This study used SEER-Medicare linked database. We identified all patients aged 66 years or older diagnosed with HNSCC as their first cancer from 1992 to 2011. We excluded those in HMO, diagnosed by death certificate or autopsy, non-SCC, unknown race, and missing month and/or year of diagnosis. Further exclusions included metastatic disease, salivary gland cancers, receiving no treatment in the first 180 days, and unknown stage. Analytic data set included oropharynx, oral cavity, nasopharynx, hypopharynx, and larynx. Primary treatment was defined as any treatment modality received within 180 days after diagnosis. Overall survival (OS) parameters were estimated across ethnic groups by the Cox regression model stratified by site and stage of cancer at diagnosis, adjusted for clinical and demographic characteristics, and propensity score weighted. Results: Our study population included 15, 547 patients. Median OS was 3.5 years (95% CI: 3.4-3.7) across all ethnic groups. African Americans (AA) had inferior outcome with median OS of 2.0 years (95% CI: 1.9-2.3) compared to 3.7 years (95% CI: 3.6-3.8) for Caucasian Americans (CA) (p < 0.0001). This difference was seen despite AA patients receiving comparable treatments and presenting at similar stage of disease, except for cancers of the oral cavity where AA were more likely to present with advanced disease (67% versus 47%; P < 0.001). The difference was most pronounced in the oropharynx where median OS was 1.9 years (95% CI: 1.7-2.1) for AA and 3.8 years (95% CI: 3.5-4.1) in CA (P < 0.0001). AA also had consistently worse OS over time from 1992 to 2011. This study clearly demonstrated AA have inferior outcomes despite similar treatments, comorbidities, age at diagnosis, stage at presentation, tumor location, year of diagnosis and sex. Conclusions: The current study demonstrates inferior overall survival for African American head and neck cancer patients independent of primary site and treatment modalities.

Sign in / Sign up

Export Citation Format

Share Document